Literature DB >> 5041103

The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy.

I C Gordon-Smith, J A Hickman, S H el-Masri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5041103     DOI： 10.1002/bjs.1800590706

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  6 in total

1.  Letter: Fibrinolysis and venous thrombosis.

Authors:  I C Gordon-Smith; J A Hickman
Journal:  Br Med J       Date:  1975-03-08

2.  Tranexamic acid and fibrinolytic activity of the vessel wall.

Authors:  B Astedt; P Liedholm
Journal:  Experientia       Date:  1974-07-15

3.  Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.

Authors:  S A Tsementzis; E R Hitchcock; C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 4.  Clinical pharmacology of aminocaproic and tranexamic acids.

Authors:  I M Nilsson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 5.  Venous thromboembolism after surgery for benign prostatic hyperplasia.

Authors:  David Bergqvist
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

6.  The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).

Authors:  J Sinclair; C D Forbes; C R Prentice; R Scott
Journal:  Urol Res       Date:  1976-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.